Loading…
Reported covered position: Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: LUNDBECK PHARMACEUTICALS LLC · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: LUNDBECK PHARMACEUTICALS LLC · Firm: CAPITOL COUNSEL LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
DAIMLER TRUCKS NORTH AMERICA via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues related to the implementation of the EPAs Greenhouse Gas (GHG) Emissions Standards for Heavy-Duty Vehicles - Phase 3.
Issues related to tariffs.
Source: Senate LDA
| NEUROCRINE BIOSCIENCES, INC |
| 14 |
| 2023–2026 |
| ZAI LAB (US) LLC | 14 | 2023–2026 |
| BAYER CORPORATION | 13 | 2023–2026 |
| DAIMLER TRUCKS NORTH AMERICA | 13 | 2023–2026 |
| TEMPUS LABS INC | 13 | 2023–2026 |
| JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS | 12 | 2023–2026 |
| BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) | 11 | 2024–2026 |
| MARCH OF DIMES INC. | 11 | 2024–2026 |
| SHARE OUR STRENGTH | 10 | 2024–2026 |
| Alnylam Pharmaceuticals, Inc. | 9 | 2025–2026 |
| BLUE EARTH DIAGNOSTICS INC | 9 | 2025–2026 |
| EMD SERONO, INC. | 9 | 2024–2026 |
| BOEHRINGER INGELHEIM ANIMAL HEALTH US | 8 | 2025–2026 |
| AMERICAN ACADEMY OF DERMATOLOGY | 7 | 2025–2026 |
| HEALTHCARE LEADERSHIP COUNCIL | 7 | 2025–2026 |
| Rite Aid Corporation | 7 | 2023–2025 |
| FOODCORPS, INC. | 6 | 2025–2026 |
| MEAD JOHNSON AND COMPANY, LLC | 6 | 2024–2025 |
| PCCA, INC. | 6 | 2025–2026 |
| AMERICAN BANKERS ASSOCIATION HSA COUNCIL | 5 | 2025–2026 |
| AMERICAN PSYCHIATRIC ASSOCIATION | 5 | 2025–2026 |
| IPSEN BIOPHARMACEUTICALS, INC. | 5 | 2025–2026 |
| AMERICAN FOOTBALL COACHES ASSOCIATION | 4 | 2025 |
| BRISTOL-MYERS SQUIBB | 4 | 2026 |
| CONTINUUS PHARMACEUTICALS | 4 | 2025–2026 |
| FIGS | 4 | 2023–2024 |
| MADRIGAL PHARMACEUTICALS, INC. | 4 | 2026 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 4 | 2025–2026 |
| AMICUS THERAPEUTICS, INC. | 3 | 2026 |
| CURIUM | 3 | 2026 |
| DISC MEDICINE | 3 | 2026 |
| GENENTECH | 3 | 2026 |
| GRANICUS, LLC | 3 | 2026 |
| L'OREAL USA S/D, INC. | 3 | 2026 |
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: LUNDBECK PHARMACEUTICALS LLC · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) · Firm: CAPITOL COUNSEL LLC
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) · Firm: CAPITOL COUNSEL LLC
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) · Firm: CAPITOL COUNSEL LLC
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) · Firm: CAPITOL COUNSEL LLC
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
Ensuring Community Access to Pharmacist Services Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) · Firm: CAPITOL COUNSEL LLC
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.
Ensuring Community Access to Pharmacist Services Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) · Firm: CAPITOL COUNSEL LLC
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.
Optimizing Postpartum Outcomes Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Optimizing Postpartum Outcomes Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Optimizing Postpartum Outcomes Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Physical Therapist Workforce and Patient Access Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Physical Therapist Workforce and Patient Access Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Physical Therapist Workforce and Patient Access Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Consolidated Appropriations Act, 2026
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) · Firm: CAPITOL COUNSEL LLC
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.
Consolidated Appropriations Act, 2026
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) · Firm: CAPITOL COUNSEL LLC
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.
Provider Reimbursement Stability Act of 2026
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
Provider Reimbursement Stability Act of 2026
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Provider Reimbursement Stability Act of 2026
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
ABC-ED Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
ABC-ED Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
ABC-ED Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: LUNDBECK PHARMACEUTICALS LLC · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) · Firm: CAPITOL COUNSEL LLC
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) · Firm: CAPITOL COUNSEL LLC
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) · Firm: CAPITOL COUNSEL LLC
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) · Firm: CAPITOL COUNSEL LLC
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: LUNDBECK PHARMACEUTICALS LLC · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: LUNDBECK PHARMACEUTICALS LLC · Firm: CAPITOL COUNSEL LLC
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SHARE OUR STRENGTH · Firm: CAPITOL COUNSEL LLC
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) · Firm: CAPITOL COUNSEL LLC
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) · Firm: CAPITOL COUNSEL LLC
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
Optimizing Postpartum Outcomes Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act.
Optimizing Postpartum Outcomes Act of 2025
Client: AMERICAN PHYSICAL THERAPY ASSOCIATION · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act.
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act.
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY · Firm: CAPITOL COUNSEL LLC
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025 and S. 891 - Bipartisan Health Care Act. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act.
ABC-ED Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
ABC-ED Act of 2025
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · Firm: CAPITOL COUNSEL LLC
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Issues related to Surface Transportation Reauthorization.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
AMERICAN PSYCHIATRIC ASSOCIATION via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues pertaining to public mental health programs, Medicare, Medicaid, substance-use disorder care, healthcare workforce and integrated care models. Issues regarding telehealth and legislation pertaining to collaborative care and mental health parity. Working for passage of the Collaborate in an Orderly and Cohesive Manner Act.
Issues pertaining to public mental health programs, Medicare, Medicaid, substance-use disorder care, healthcare workforce and integrated care models.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRISTOL-MYERS SQUIBB via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding approved and pipeline products, and related policy. FDA Clinical Trial reform proposals.
Issues regarding approved and pipeline products, and related policy. 340 program issues.
Issues regarding approved and pipeline products, and related policy. IRA price negotiation. MFN proposals, including GLOBE and GUARD and impacts on innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MADRIGAL PHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
FDA and regulatory issues related to the biopharmaceutical industry.
FDA and regulatory issues related to the biopharmaceutical industry.
FDA and regulatory issues related to the biopharmaceutical industry, including CMMI Drug Pricing Models.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues related to tariffs.
Public health issues impacting patient access to treatments. Updates and reforms to regulation of treatment development and research.
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Legislative issues related to Medicare Part B.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SHARE OUR STRENGTH via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Medicare quality standards for hospitals and transplant programs. Education on antibiotic resistance, antibiotic stewardship, and related Medicare quality standards.
Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Monitor implementation of health care provider provisions of the Dr. Lorna Breen Health Care Provider Protection Act, Public Law No: 117-105.
Monitor implementation of accreditation of military emergency transportation.
IPSEN BIOPHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Ensure Medicare beneficiary access to Medicare covered prescription drugs and enable beneficiaries to spread cost-sharing requirements, including monitoring implementation of related provisions in the Inflation Reduction Act, P.L. 117-169.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
340B Program issues and patient access to pharmaceuticals. Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research, medical countermeasures, and novel product development.
Implementation issues affecting patient access to Medicare covered pharmaceuticals and biologics, including reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including advocacy related to the Most Favored Nation and related demonstration initiatives.
BAYER CORPORATION via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Medicare coverage and reimbursement issues related to Part B and D Drug Reimbursement. Advocacy related to the Farm Bill reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Medicare Part B coverage and reimbursement issues; Medicare Part D coverage issues. AI in health care. 340B Program issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN BANKERS ASSOCIATION HSA COUNCIL via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues related to Health Savings Accounts.
Issues related to Health Savings Accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF DERMATOLOGY via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Support Congressional Skin Cancer Caucus; legislative issues related to the prevention of skin cancer.
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.
L'OREAL USA S/D, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues related to the implementation of MoCRA (Modernization of Cosmetics Regulation Act), sunscreen regulation and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARCH OF DIMES INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Advice and advocacy related to health care issues focused on maternal health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
GLAXOSMITHKLINE LLC via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. Reauthorization of the Prescription Drug User Fee Act (FDUFA).
Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. Reauthorization of the Prescription Drug User Fee Act (FDUFA).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE LEADERSHIP COUNCIL via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Monitor the implementation of healthcare quality, cost, and access, and related healthcare reform efforts. Monitor issues related to artificial intelligence and cybersecurity.
Enhance Center for Medicare & Medicaid Innovation quality initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding the availability and pricing of prescription drugs.
Issues regarding the availability and pricing of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CURIUM via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding radiopharmaceutical New Drug Application (NDA) approvals.
Filing targets: SENATE
BLUE EARTH DIAGNOSTICS, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Advise on health policy matters, Medicare reimbursement, and FDA related matters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZAI LAB (US) LLC via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPUS LABS, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
Reimbursement and coding for AI in health care.
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.
Legislative and regulatory issues related to independent pharmacists. PBM reform, including implementation of Public Law No. 119-75. DoD / TRICARE pharmacy benefit program audit.
Filing targets: Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LUNDBECK PHARMACEUTICALS LLC via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRANICUS, LLC via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Supporting administration efforts to communicate with constituents utilizing GovDelivery.
Fostering congressional and executive branch engagement to expand adoption of Granicus's FedRAMP-certified digital communications and citizen engagement platform across federal agencies.
Filing targets: Agriculture, Dept of (USDA), Energy, Dept of, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Social Security Administration (SSA), Treasury, Dept of, White House Office
BOEHRINGER INGELHEIM ANIMAL HEALTH US via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding FDA animal drug approval process.
Issues regarding FDA animal drug approval process.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PHYSICAL THERAPY ASSOCIATION via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF EMERGENCY PHYSICIANS via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Non-Compete agreement restrictions.
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · third_quarter · Q3
Issues regarding FDA guidance on Platform Technology Platform Technology Designation Program for Drug Development. PDUFA reauthorization, Clinical Trial / IND reform.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MARCH OF DIMES INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Advice and advocacy related to health care issues focused on maternal health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHARE OUR STRENGTH via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Legislative issues related to Medicare Part B.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Monitor implementation of health care provider provisions of the Dr. Lorna Breen Health Care Provider Protection Act, Public Law No: 117-105.
Monitor implementation of accreditation of military emergency transportation.
Medicare quality standards for hospitals and transplant programs. Education on antibiotic resistance, antibiotic stewardship, and related Medicare quality standards.
HEALTHCARE LEADERSHIP COUNCIL via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Enhance Center for Medicare & Medicaid Innovation quality initiatives.
Monitor the implementation of healthcare quality, cost, and access, and related healthcare reform efforts. Monitor issues related to artificial intelligence and cybersecurity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIMLER TRUCKS NORTH AMERICA via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues related to the implementation of the EPAs Greenhouse Gas (GHG) Emissions Standards for Heavy-Duty Vehicles - Phase 3.
Issues related to tariffs.
Issues related to Surface Transportation Reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PSYCHIATRIC ASSOCIATION via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues pertaining to public mental health programs, Medicare, Medicaid, substance-use disorder care, healthcare workforce and integrated care models.
Issues pertaining to public mental health programs, Medicare, Medicaid, substance-use disorder care, healthcare workforce and integrated care models. Issues regarding telehealth and legislation pertaining to collaborative care and mental health parity. Working for passage of the Collaborate in an Orderly and Cohesive Manner Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
L'OREAL USA S/D, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues related to the implementation of MoCRA (Modernization of Cosmetics Regulation Act), sunscreen regulation and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IPSEN BIOPHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Ensure Medicare beneficiary access to Medicare covered prescription drugs and enable beneficiaries to spread cost-sharing requirements, including monitoring implementation of related provisions in the Inflation Reduction Act, P.L. 117-169.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Implementation issues affecting patient access to Medicare covered pharmaceuticals and biologics, including reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including advocacy related to the Most Favored Nation and related demonstration initiatives.
340B Program issues and patient access to pharmaceuticals. Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research, medical countermeasures, and novel product development.
FOODCORPS, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · 2T
Issues regarding childrens nutrition, and school meals.
Filing targets: Health & Human Services, Dept of (HHS)
BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
Issues related to tariffs.
Public health issues impacting patient access to treatments. Updates and reforms to regulation of treatment development and research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Medicare coverage and reimbursement issues related to Part B and D Drug Reimbursement. Advocacy related to the Farm Bill reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Medicare Part B coverage and reimbursement issues; Medicare Part D coverage issues. AI in health care. 340B Program issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN BANKERS ASSOCIATION HSA COUNCIL via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues related to Health Savings Accounts.
Issues related to Health Savings Accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF DERMATOLOGY via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Support Congressional Skin Cancer Caucus; legislative issues related to the prevention of skin cancer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZAI LAB (US) LLC via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPUS LABS, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Reimbursement and coding for AI in health care.
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Legislative and regulatory issues related to independent pharmacists. PBM reform, including implementation of Public Law No. 119-75
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.
Filing targets: Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MADRIGAL PHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
FDA and regulatory issues related to the biopharmaceutical industry, including CMMI Drug Pricing Models.
FDA and regulatory issues related to the biopharmaceutical industry.
FDA and regulatory issues related to the biopharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LUNDBECK PHARMACEUTICALS LLC via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRANICUS, LLC via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Fostering congressional and executive branch engagement to expand adoption of Granicus's FedRAMP-certified digital communications and citizen engagement platform across federal agencies.
Supporting administration efforts to communicate with constituents utilizing GovDelivery.
Filing targets: Agriculture, Dept of (USDA), Energy, Dept of, HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Social Security Administration (SSA), Treasury, Dept of
DISC MEDICINE via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Engagement with Congress regarding FDA approvals for rare diseases.
Engagement with Congress regarding FDA approvals for rare diseases.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CONTINUUS PHARMACEUTICALS via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding incentives to rehore pharmaceutical manufacturing.
Issues regarding incentives to reshore pharmaceutical manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRISTOL-MYERS SQUIBB via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding approved and pipeline products, and related policy.
Issues regarding approved and pipeline products, and related policy.
Issues regarding approved and pipeline products, and related policy. 340 program issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEHRINGER INGELHEIM ANIMAL HEALTH US via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding FDA animal drug approval process.
Issues regarding FDA animal drug approval process.
Filing targets: Food & Drug Administration (FDA), SENATE
AMICUS THERAPEUTICS, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · 2T
Legislative and regulatory issues affecting SMID rare disease biotech companies.
Legislative and regulatory issues affecting SMID rare disease biotech companies. FDA approvals of rare diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PHYSICAL THERAPY ASSOCIATION via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF EMERGENCY PHYSICIANS via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding FDA guidance on Platform Technology Platform Technology Designation Program for Drug Development.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding the availability and pricing of prescription drugs.
Issues regarding the availability and pricing of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CURIUM via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding radiopharmaceutical New Drug Application (NDA) approvals.
Filing targets: SENATE
BLUE EARTH DIAGNOSTICS, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Advise on health policy matters, Medicare reimbursement, and FDA related matters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC. via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
GLAXOSMITHKLINE LLC via CAPITOL COUNSEL LLC
2026 · second_quarter · Q2
Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.
Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GRANICUS, LLC via CAPITOL COUNSEL LLC
2026 · second_quarter · RR
Fostering congressional and executive branch engagement to expand adoption of Granicus's FedRAMP-certified digital communications and citizen engagement platform across federal agencies.
Fostering congressional and executive branch engagement to expand adoption of Granicus's FedRAMP-certified digital communications and citizen engagement platform across federal agencies.
CURIUM via CAPITOL COUNSEL LLC
2026 · second_quarter · RR
Issues regarding radiopharmaceutical New Drug Application (NDA) approvals.
SHARE OUR STRENGTH via CAPITOL COUNSEL LLC
2026 · first_quarter · 1A
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2027 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
BAYER CORPORATION via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Medicare coverage and reimbursement issues related to Part B and D Drug Reimbursement. Advocacy related to the Farm Bill reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Legislative issues related to Medicare Part B.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRISTOL-MYERS SQUIBB via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding approved and pipeline products, and related policy.
Issues regarding approved and pipeline products, and related policy. 340 program issues.
Issues regarding approved and pipeline products, and related policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARCH OF DIMES INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Advice and advocacy related to health care issues focused on maternal health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF DERMATOLOGY via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.
Support Congressional Skin Cancer Caucus; legislative issues related to the prevention of skin cancer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE LEADERSHIP COUNCIL via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Monitor the implementation of healthcare quality, cost, and access, and related healthcare reform efforts. Monitor issues related to artificial intelligence and cybersecurity.
Enhance Center for Medicare & Medicaid Innovation quality initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding the availability and pricing of prescription drugs.
Issues regarding the availability and pricing of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE EARTH DIAGNOSTICS, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Advise on health policy matters, Medicare reimbursement, and FDA related matters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHARE OUR STRENGTH via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
Issues regarding childhood hunger and related provisions in the Farm Bill, the FY 2026 Agriculture Appropriations bill. Supplemental Nutrition Assistance Program (SNAP) provisions in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21 budget reconciliation package.
JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Medicare quality standards for hospitals and transplant programs. Education on antibiotic resistance, antibiotic stewardship, and related Medicare quality standards.
Monitor healthcare reform and quality initiatives, including implementation of related provisions in the Affordable Care Act. Monitor implementation of health care provider provisions of the Dr. Lorna Breen Health Care Provider Protection Act, Public Law No: 117-105.
Monitor implementation of accreditation of military emergency transportation.
IPSEN BIOPHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Ensure Medicare beneficiary access to Medicare covered prescription drugs and enable beneficiaries to spread cost-sharing requirements, including monitor implementation of related provisions in the Inflation Reduction Act, P.L. 117-169.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
340B Program issues and patient access to pharmaceuticals. Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research, medical countermeasures, and novel product development.
Implementation issues affecting patient access to Medicare covered pharmaceuticals and biologics, including reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including advocacy related to the Most Favored Nation and related demonstration initiatives.
FOODCORPS, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding childrens nutrition, and school meals.
Filing targets: Health & Human Services, Dept of (HHS)
BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21
Issues related to tariffs.
Public health issues impacting patient access to treatments. Updates and reforms to regulation of treatment development and research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Medicare Part B coverage and reimbursement issues; Medicare Part D coverage issues. AI in health care. 340B Program issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ZAI LAB (US) LLC via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PCCA, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · 1T
Issues regarding drug compounding of generic drugs in shortage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
Legislative and regulatory issues related to independent pharmacists. PBM Issues, including H.R./S._Modernizing and Ensuring PBM Accountability Act. H.R./S._Lower Costs, More Transparency Act.
Filing targets: Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MADRIGAL PHARMACEUTICALS, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
FDA and regulatory issues related to the biopharmaceutical industry.
FDA and regulatory issues related to the biopharmaceutical industry, including CMMI Drug Pricing Models.
FDA and regulatory issues related to the biopharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMICUS THERAPEUTICS, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Legislative and regulatory issues affecting SMID rare disease biotech companies. FDA approvals of rare diseases.
Legislative and regulatory issues affecting SMID rare disease biotech companies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BANKERS ASSOCIATION HSA COUNCIL via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues related to Health Savings Accounts.
Issues related to Health Savings Accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAIMLER TRUCKS NORTH AMERICA via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Implementation of the Inflation Reduction Act 2022 (P.L. No: 117-169), related to Tax Credit 45W. Issues related to the implementation of the EPAs Greenhouse Gas (GHG) Emissions Standards for Heavy-Duty Vehicles - Phase 3. Advocacy related to zero emission vehicle policies.
Implementation of the Inflation Reduction Act 2022 (P.L. No: 117-169), related to Tax Credit 45W. Issues related to the implementation of the EPAs Greenhouse Gas (GHG) Emissions Standards for Heavy-Duty Vehicles - Phase 3. Advocacy related to zero emission vehicle policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PSYCHIATRIC ASSOCIATION via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues pertaining to public mental health programs, Medicare, Medicaid, substance-use disorder care, healthcare workforce and integrated care models. Issues regarding telehealth and legislation pertaining to collaborative care and mental health parity. Working for passage of the Collaborate in an Orderly and Cohesive Manner Act.
Issues pertaining to public mental health programs, Medicare, Medicaid, substance-use disorder care, healthcare workforce and integrated care models.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
L'OREAL USA S/D, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues related to the implementation of MoCRA (Modernization of Cosmetics Regulation Act), sunscreen regulation and innovation.
LUNDBECK PHARMACEUTICALS LLC via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._Modernizing and Ensuring PBM Accountability Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DISC MEDICINE via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Engagement with Congress regarding FDA approvals for rare diseases.
Engagement with Congress regarding FDA approvals for rare diseases.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CONTINUUS PHARMACEUTICALS via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding incentives to reshore pharmaceutical manufacturing.
Issues regarding incentives to rehore pharmaceutical manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BOEHRINGER INGELHEIM ANIMAL HEALTH US via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding FDA animal drug approval process.
Issues regarding FDA animal drug approval process.
Filing targets: Food & Drug Administration (FDA), SENATE
AMERICAN PHYSICAL THERAPY ASSOCIATION via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF EMERGENCY PHYSICIANS via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPUS LABS, INC. via CAPITOL COUNSEL LLC
2026 · first_quarter · Q1
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Issues regarding potential changes to structure and reimbursement for Medicare Part D; Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Reimbursement and coding for AI in health care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE